Chosidow O. Clinical practices. Scabies. N Engl J Med. 2006;354:1718-1727.
Heukelbach J, Feldmeier H. Scabies. Lancet. 2006;367:1767-1774.
Hengge UR, Currie BJ, Jager G, et al. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis. 2006;6:769-779.
Johnston G, Sladden M. Scabies: diagnosis and treatment. BMJ. 2005;331:619-622.
Strong M, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev. 2007;3:CD000320.
Chouela E, Abeldano A, Pellerano G, et al. Diagnosis and treatment of scabies: a practical guide. Am J Clin Dermatol. 2002;3:9-18.
Johnstone P, Strong M. Scabies. Clin Evid. 2006:2284-2290.
1. Chosidow O. Clinical practices. Scabies. N Engl J Med. 2006;354:1718-1727.
2. Guldbakke KK, Khachemoune A. Crusted scabies: a clinical review. J Drugs Dermatol. 2006:221-227.
3. Steer AC, Jenney AW, Kado J, et al. High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis. 2009;3:467.
4. Walton SF, Currie BJ. Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev. 2007;20:268-279.
5. Heukelbach J, Feldmeier H. Scabies. Lancet. 2006;367:1767-1774.
6. McCarthy JS, Kemp DJ, Walton SF, et al. Scabies: more than just an irritation. Postgrad Med J. 2004;80:382-387.
7. Heukelbach J, Wilcke T, Winter B, et al. Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in Brazil. Br J Derm. 2005;153:150-156.
8. Hengge UR, Currie BJ, Jager G, et al. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis. 2006;6:769-779.
9. Johnston G, Sladden M. Scabies: diagnosis and treatment. BMJ. 2005;331:619-622.
10. Roberts LJ, Huffam SE, Walton SF, et al. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect. 2005;50:375-381.
11. Mellanby K. The transmission of scabies. BMJ. 1941;2:405-406.
12. Leung V, Miller M. Detection of scabies: a systematic review of diagnostic methods. Can J Infect Dis Med Microbiol. 2011;22:143-146.
13. Argenziano G, Fabbrocini G, Delfino M. Epiluminescence microscopy. A new approach to in vivo detection of Sarcoptes scabiei. Arch Dermatol. 1997;133:751-753.
14. Dupuy A, Dehen L, Bourrat E, et al. Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol. 2007;56:53-62.
15. Falk ES, Eide TJ. Histologic and clinical findings in human scabies. Int J Dermatol. 1981;20:600-605.
16. Bergman JN, Dodd WA, Trotter MJ, et al. Crusted scabies in association with human T-cell lymphotropic virus 1. J Cutan Med Surg. 1999;3:148-152.
17. Del Giudice P, Sainte Marie D, Gerard Y, et al. Is crusted (Norwegian) scabies a marker of adult T cell leukemia/lymphoma in human T lymphotropic virus type I-seropositive patients? J Infect Dis. 1997;176:1090-1092.
18. Slawsky LD, Maroon M, Tyler WB, et al. Association of scabies with a bullous pemphigoid-like eruption. J Am Acad Dermatol. 1996;34:878-879.
19. Whiting DA, Howard AK, Parker D, et al. Disorders of cutaneous appendages. In: Barnhill RL, Crowson AN, ed. Textbook of dermatopathology, 2nd ed. New York, NY: McGraw-Hill; 2004:229-268.
20. Rapini RP. Bacterial infections. In: Barnhill RL, Crowson AN, ed. Textbook of dermatopathology, 2nd ed. New York, NY: McGraw-Hill; 2004:439-478.
21. Otley C, Hall RP. Dermatitis herpetiformis. Dermatol Clin. 1990;8:759-769.
22. Zillikens D. Acquired skin disease of hemidesmosomes. J Dermatol Sci. 1999;20:134-154.
23. Matz H, Orion E, Wolf R. Pruritic urticarial papules and plaques of pregnancy: polymorphic eruption of pregnancy (PUPPP). Clin Dermatol. 2006;24:105-108.
24. Strong M, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev. 2007;3:CD000320.
25. Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. N Engl J Med. 2010;362:717-725.
26. Johnstone P, Strong M. Scabies. BMJ Clinical Evidence handbook: scabies. June 2009. http://clinicalevidence.bmj.com/ (last accessed 13 March 2017).
27. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015: ectoparasitic infections. http://www.cdc.gov/ (last accessed 13 March 2017).
28. Salavastru CM, Chosidow O, Boffa MJ, et al. European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1248-1253.
29. Chhaiya SB, Patel VJ, Dave JN, et al. Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies. Indian J Dermatol Venereol Leprol. 2012;78:605-610.
30. Goldust M, Rezaee E, Raghifar R, et al. Treatment of scabies: the topical ivermectin vs. permethrin 2.5% cream. Ann Parasitol. 2013;59:79-84.
31. Ahmad HM, Abdel-Azim ES, Abdel-Aziz RT. Clinical efficacy and safety of topical versus oral ivermectin in treatment of uncomplicated scabies. Dermatol Ther. 2016 Jan-Feb;29(1):58-63.
32. Usha V, Gopalakrishnan Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol. 2000;42:236-240.
33. Bachewar NP, Thawani VR, Mali SN, et al. Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies. Indian J Pharmacol. 2009;41:9-14
34. Goldust M, Rezaee E, Hemayat S. Treatment of scabies: comparison of permethrin 5% versus ivermectin. J Dermatol. 2012;39:545-547.
35. Huffam SE, Currie BJ. Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis. 1998;2:152-154.
36. Chouela E, Abeldano A, Pellerano G, et al. Diagnosis and treatment of scabies: a practical guide. Am J Clin Dermatol. 2002;3:9-18.
37. Johnstone P, Strong M. Scabies. Clin Evid. 2006:2284-2290.
38. Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol. 1998;38:877-895.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台